|
Volumn 30, Issue 6, 2010, Pages 734-740
|
Discovery of chrysoeriol, a PI3K-AKT-mTOR pathway inhibitor with potent antitumor activity against human multiple myeloma cells in vitro.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CHRYSOERIOL;
FLAVONE DERIVATIVE;
MTOR PROTEIN, HUMAN;
PHOSPHATIDYLINOSITOL 3 KINASE;
PROTEIN KINASE B;
TARGET OF RAPAMYCIN KINASE;
ARTICLE;
ASPALATHUS;
CELL CYCLE;
CELL PROLIFERATION;
CHEMISTRY;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
ISOLATION AND PURIFICATION;
METABOLISM;
MULTIPLE MYELOMA;
PATHOLOGY;
PHYSIOLOGY;
SIGNAL TRANSDUCTION;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ASPALATHUS;
CELL CYCLE;
CELL LINE, TUMOR;
CELL PROLIFERATION;
FLAVONES;
HUMANS;
MULTIPLE MYELOMA;
PHOSPHATIDYLINOSITOL 3-KINASES;
PROTO-ONCOGENE PROTEINS C-AKT;
SIGNAL TRANSDUCTION;
TOR SERINE-THREONINE KINASES;
|
EID: 84876033137
PISSN: 16720733
EISSN: None
Source Type: Journal
DOI: 10.1007/s11596-010-0649-4 Document Type: Article |
Times cited : (24)
|
References (0)
|